Literature DB >> 15189164

Opioid receptors.

Maria Waldhoer1, Selena E Bartlett, Jennifer L Whistler.   

Abstract

Opioid receptors belong to the large superfamily of seven transmembrane-spanning (7TM) G protein-coupled receptors (GPCRs). As a class, GPCRs are of fundamental physiological importance mediating the actions of the majority of known neurotransmitters and hormones. Opioid receptors are particularly intriguing members of this receptor family. They are activated both by endogenously produced opioid peptides and by exogenously administered opiate compounds, some of which are not only among the most effective analgesics known but also highly addictive drugs of abuse. A fundamental question in addiction biology is why exogenous opioid drugs, such as morphine and heroin, have a high liability for inducing tolerance, dependence, and addiction. This review focuses on many aspects of opioid receptors with the aim of gaining a greater insight into mechanisms of opioid tolerance and dependence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189164     DOI: 10.1146/annurev.biochem.73.011303.073940

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  207 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

2.  Signaling cascades for δ-opioid receptor-mediated inhibition of GABA synaptic transmission and behavioral antinociception.

Authors:  Zhi Zhang; Zhizhong Z Pan
Journal:  Mol Pharmacol       Date:  2011-12-05       Impact factor: 4.436

3.  Structural basis for μ-opioid receptor binding and activation.

Authors:  Adrian W R Serohijos; Shuangye Yin; Feng Ding; Josee Gauthier; Dustin G Gibson; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

4.  Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts.

Authors:  Yu Qiu; Yan Wang; Ping-Yee Law; Hong-Zhuan Chen; Horace H Loh
Journal:  Mol Pharmacol       Date:  2011-04-25       Impact factor: 4.436

5.  Synergism between fentanyl and tramadol in tonic inflammatory pain: the orofacial formalin test.

Authors:  Hugo F Miranda; Viviana Noriega; Ramiro J Zepeda; Fernando Sierralta; Juan C Prieto
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 6.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

7.  Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.

Authors:  N Kabli; N Martin; T Fan; T Nguyen; A Hasbi; G Balboni; B F O'Dowd; S R George
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

8.  AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.

Authors:  Kathryn A Seely; Lisa K Brents; Lirit N Franks; Maheswari Rajasekaran; Sarah M Zimmerman; William E Fantegrossi; Paul L Prather
Journal:  Neuropharmacology       Date:  2012-07-04       Impact factor: 5.250

Review 9.  Post-operative Weaning of Opioids After Ambulatory Surgery: the Importance of Physician Stewardship.

Authors:  Brandon Roth; Adjoa Boateng; Allison Berken; Daniel Carlyle; Nalini Vadivelu
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

Review 10.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.